<DOC>
	<DOCNO>NCT00288379</DOCNO>
	<brief_summary>To compare effect formoterol alone ( Oxis® TurbuhalerÒ ) fix combination formoterol budesonide ( Symbicort® TurbuhalerÒ ) airway responsiveness marker inflammation , induce repeat low-dose allergen challenge allergic patient mild asthma</brief_summary>
	<brief_title>SMILDA - Symbicort®Turbuhaler® Allergan Challenge Study Allergic Patients With Mild Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Budesonide , Formoterol Fumarate Drug Combination</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>A diagnosed history asthma least 6 month Mild stable asthma , use β2agonists need last 4 week . FEV1 &gt; 70 % predict normal value ( postbronchodilator value ) . Skin prick test positive pollen , animal dander house dust mite . Any significant respiratory disease , asthma . Upper low respiratory tract infection within 4 week inclusion . Use : 1. inhaled glucocorticosteroid treatment last 8 week prior inclusion ever use oral glucocorticoid treatment asthma . 2. inhaled longacting oral b2agonists , anticholinergic bronchodilator , cromones , antihistamine , theophylline antileukotrienes within 2 week screen . 3. regular NSAIDs</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Asthma</keyword>
	<keyword>allergen challenge</keyword>
	<keyword>airway responsiveness</keyword>
	<keyword>airway inflammation</keyword>
	<keyword>Symbicort®</keyword>
</DOC>